Amikacin description: Difference between revisions
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Amikacin}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMIKACIN SULFATE INJECTION [TEVA PARENTERAL MEDICINES, INC.] | ur..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Description== | |||
Amikacin Sulfate Injection USP is a semi-synthetic aminoglycoside antibiotic derived from kanamycin. D-Streptamine,O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2) (salt). | |||
{| | |||
| [[File:Amikacin01.jpg|400px|thumb]] | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMIKACIN SULFATE INJECTION [TEVA PARENTERAL MEDICINES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ec3129b-c53b-4bdb-913d-a2d0060fa140#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | |} | ||
The dosage form is supplied as a sterile, colorless to light straw-colored solution for intramuscular or intravenous use. The 500 mg per 2 mL vial and the 1 gram per 4 mL vial each contain, per mL, 250 mg amikacin USP (as the sulfate), 2.5% sodium citrate dihydrate, 0.66% sodium metabisulfite, and water for injection, q.s. pH is adjusted with sulfuric acid and/or, if necessary, sodium hydroxide. The pH is 3.5 to 5.5.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMIKACIN SULFATE INJECTION [TEVA PARENTERAL MEDICINES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ec3129b-c53b-4bdb-913d-a2d0060fa140#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 01:11, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Description
Amikacin Sulfate Injection USP is a semi-synthetic aminoglycoside antibiotic derived from kanamycin. D-Streptamine,O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2) (salt).
 |
The dosage form is supplied as a sterile, colorless to light straw-colored solution for intramuscular or intravenous use. The 500 mg per 2 mL vial and the 1 gram per 4 mL vial each contain, per mL, 250 mg amikacin USP (as the sulfate), 2.5% sodium citrate dihydrate, 0.66% sodium metabisulfite, and water for injection, q.s. pH is adjusted with sulfuric acid and/or, if necessary, sodium hydroxide. The pH is 3.5 to 5.5.[1]
References
Adapted from the FDA Package Insert.